Methylphenidate treatment in children with ADHD with dysregulation profile is associated with worse sleep outcomes.

Tocilizumab and rituximab reduce relapse rates and disability progression in NMOSD, with tocilizumab provides extra benefits in MOGAD.

Higher job strain is associated with increased sleep disturbances over time among workers in the United States.

Higher levels of environmental metals in urine are linked to worse cognitive performance and a greater risk of developing dementia.

Galcanezumab provided greater reductions in migraine frequency, resulting in a shift from chronic to episodic migraine over a 12-month period compared with placebo.

An expert panel of behavioral sleep medicine professionals recently released an expert consensus statement on CBT for nightmares.

During the 2010-2011 to 2024-2025 influenza seasons, 9% of pediatric influenza-associated deaths had influenza-associated encephalopathy or encephalitis (IAE).

Engaging in physical activity seems to be beneficial to the mental health of women with chronic pelvic pain disorders (CPPD).

Telemedicine adoption is associated with modestly lower use of low-value, point-of-care testing among Medicare beneficiaries.

The age-standardized mortality rate for suicide decreased globally from 1990 to 2021, with variation by age, sex, and geographic region.

Among patients with OSA, sleep surgery vs CPAP therapy or no treatment reduces the risk for motor vehicle accidents.

The FDA has granted Breakthrough Therapy designation to radiprodil for the treatment of seizures associated with GRIN-related neurodevelopmental disorder with GoF mutations.